期刊文献+

Appraisal of the current guidelines for management of cholangiocarcinoma-using the Appraisal of Guidelines Research and Evaluation Ⅱ (AGREE Ⅱ) Instrument 被引量:7

原文传递
导出
摘要 Cholangiocarcinoma(CC)is the second most common primary liver tumour.High-quality guidelines are essential for effective patient stratification and individualised treatment.This study aimed to appraise the methodological quality of existing guidelines for the resection of CC using the Appraisal of Guidelines for Research&Evaluation(AGREE II)instrument.A systematic search of the literature in Cochrane,PubMed,Google Scholar,and Embase was performed.Assessment of the clinical practice guidelines(CPGs)and consensuses was performed using the AGREE II instrument by four clinicians experienced in surgical practice and the AGREE II appraisal method.Literature searches identified 13 guidelines of highly variable quality according to the AGREE II criteria.The guidelines scored well in certain domains such as scope&purpose(median score across all guidelines;65%),clarity of presentation(76%),and editorial independence(56%).However,they scored poorly for applicability(13%),rigour of development(30%),and stakeholder involvement(39%).None of the 13 guidelines was recommended universally for use without modification.Overall,the methodological quality of guidelines on the surgical management of CC is poor.Future updates should address and modify shortcomings detected by the AGREE II instrument,thereby facilitating better patient stratification and individualised treatment strategies.
出处 《Hepatobiliary Surgery and Nutrition》 SCIE 2020年第2期126-135,中插1,共11页 肝胆外科与营养(英文)
作者简介 corresponding author:Paschalis Gavriilidis.Department of Hepato-Pancreato-Biliary and Transplant Surgery,Queen Elizabeth University Hospitals Birmingham NHS Foundation Trust,Birmingham,B151NU,UK.Email:pgavrielidis@yahoo.com.
  • 相关文献

参考文献1

  • 1Jian-qiang Cai,Shou-wang Cai,Wen-ming Cong,Min-shan Chen,Ping Chen,Xiao-ping Chen,Yan-ling Chen,Yi-fa Chen,Chao-liu Dai,Qiang Huang,Zhi-yong Huang,Bo Jiang,Bin Jiang,Ke-wei Jiang,Bo Li,Zong-fangLi,Li-jian Liang,Bin Liu,Hui-chun Liu,Lian-xin Liu,Qing-guang Liu,Rong Liu,Ying-bin Liu,Jian-guo Lu,Shi-chun Lu,Yi Lu,Yi-lei Mao,Bin Mei,Jun Niu,Bao-gang Peng,Xiao Qin,Yu-dong Qiu,Guang-yi Wang,Yao-don Wangg,Zhi-ming Wang,Ren-hua Wan,Ya-fu Wu,Bao-cai Xing,Feng Xia,Ge-liang Xu,Jia-mei Yang,Xiao-fang Yu,Yong Zeng,Yong-yi Zeng,Bi-xiang Zhang,Bin-hao Zhang,Qi-yu Zhang,Shui-jun Zhang,Wan-guang Zhang,Yong-jie Zhang,Zhi-wei Zhang,Dong Zhou,Wei-ping Zhou.Diagnosis and Treatment of Cholangiocarcinoma: A Consensus from Surgical Specialists of China[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2014,34(4):469-475. 被引量:3

二级参考文献26

  • 1Bismuth HCD. Hepatobiliary malignancy. London: Edward Arnold, 1994.
  • 2O'Grady JG. Treatment options for other hepatic malignancies. Liver Transpl, 2000,6(6 suppl 2):S23-S2 9.
  • 3de Groen PC, Gores GJ, LaRusso NF, et al. Biliary tract cancers. N Engl J Med, 1999,341(18): 1368-1378.
  • 4Taylor-Robinson SD, Toledano MB, Arora S, et al. Increase in mortality rates from intrahepatic cholangi- ocarcinoma in England and Wales 1968-1998. Gut, 2001,48(6):816-820.
  • 5Chapman RW. Risk factors for biliary tract carcinogenesis. Ann Oneol, 1999,10 (Suppl 4):308-311.
  • 6Ramage JK, Donaghy A, Farrant JM, et al. Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology, 1995,108(3):865-869.
  • 7Patel AH, Hamois DM, Klee GC et al. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol, 2000,95(1):204-207.
  • 8Hultcrantz R, Olsson R, Danielsson A, et al. A 3-year prospective study on serum tumor markers used for detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. J Hepatol, 1999,30(4):669-673.
  • 9Gores GJ. Early detection and treatment of cholan- giocarcinoma. Liver Transpl, 2000,6(6 Suppl):S30-S34.
  • 10Kuszyk BS, Soyer P, Bluemke DA, et al. Intrahepatic cholangiocarcinoma: the role of imaging in detection and staging. Crit Rev Diagn Imaging, 1997,38(1):59-88.

共引文献2

同被引文献49

引证文献7

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部